ISSN 0303-5212
 

Original Research 
RMJ. 2020; 45(4): 810-812


Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery

Maha Shahbaz, Shamshad Ali, Saqib Siddiq, Alina Mustafa, Khawaja Mohsin Ihsan, Fiza Azhar.

Abstract
Objective: To evaluate the efficacy of nepafenac 0.1% in maintaining mydriasis during phacoemulsification surgery.
Methodology: This randomised control study of six-month duration was performed on 120 patients who were randomized in 2 groups. The study group was given 3 drops of nepafenac 1 day prior to surgery and 4 drops on the day of surgery in addition to the preoperative dilating drops (tropicamide 1% and epinephrine 0.5%) one hour before surgery, repeated after 30 minutes. Control group received only pre-operative dilating drops. Calipers were used to measure pupil size immediately before and at end of surgery. The difference in size was noted and the decrease in pupil size was calculated using SPSS 21.0. p<0.05 was considered significant.
Results: Out of 120 patients, 42(35%) were male and 78(65%) female. The mean age was 52.13±7.34 years in control group and 52.93±7.09 years in nepafenac group. At baseline in nepafenac group, pupil size was 7.74±0.92 mm and 6.3±0.99 mm at the end of surgery. Mean decrease was 0.9±0.89 mm. In the control group, pupil size was 7.6±0.61mm before surgery and 5.84±0.56 mm at end of surgery. Mean decrease in pupil size was 1.76±0.81mm. The difference in the two groups was significant (p<0.001).
Conclusion: The use of nepafenac 0.1% during phacoemulsification surgery can be beneficial in maintaining mydriasis.

Key words: Nepafenac, phacoemulsification, cataract.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Maha Shahbaz
Articles by Shamshad Ali
Articles by Saqib Siddiq
Articles by Alina Mustafa
Articles by Khawaja Mohsin Ihsan
Articles by Fiza Azhar
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Shahbaz M, Ali S, Siddiq S, Mustafa A, Ihsan KM, Azhar F. Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. RMJ. 2020; 45(4): 810-812.


Web Style

Shahbaz M, Ali S, Siddiq S, Mustafa A, Ihsan KM, Azhar F. Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. https://www.rmj.org.pk/?mno=82965 [Access: December 04, 2023].


AMA (American Medical Association) Style

Shahbaz M, Ali S, Siddiq S, Mustafa A, Ihsan KM, Azhar F. Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. RMJ. 2020; 45(4): 810-812.



Vancouver/ICMJE Style

Shahbaz M, Ali S, Siddiq S, Mustafa A, Ihsan KM, Azhar F. Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. RMJ. (2020), [cited December 04, 2023]; 45(4): 810-812.



Harvard Style

Shahbaz, M., Ali, . S., Siddiq, . S., Mustafa, . A., Ihsan, . K. M. & Azhar, . F. (2020) Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. RMJ, 45 (4), 810-812.



Turabian Style

Shahbaz, Maha, Shamshad Ali, Saqib Siddiq, Alina Mustafa, Khawaja Mohsin Ihsan, and Fiza Azhar. 2020. Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. Rawal Medical Journal, 45 (4), 810-812.



Chicago Style

Shahbaz, Maha, Shamshad Ali, Saqib Siddiq, Alina Mustafa, Khawaja Mohsin Ihsan, and Fiza Azhar. "Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery." Rawal Medical Journal 45 (2020), 810-812.



MLA (The Modern Language Association) Style

Shahbaz, Maha, Shamshad Ali, Saqib Siddiq, Alina Mustafa, Khawaja Mohsin Ihsan, and Fiza Azhar. "Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery." Rawal Medical Journal 45.4 (2020), 810-812. Print.



APA (American Psychological Association) Style

Shahbaz, M., Ali, . S., Siddiq, . S., Mustafa, . A., Ihsan, . K. M. & Azhar, . F. (2020) Efficacy of nepafenac in maintaining mydriasis during phacoemulsification surgery. Rawal Medical Journal, 45 (4), 810-812.